Skip to main content
Caplight Logo









Genestack

Genestack

Private
CambridgeHealthcare & Life Scienceshttps://genestack.com/

Last Round

Grant

Feb 1, 2016

Total Funding Raised

$130,000

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Genestack is a life sciences informatics company that provides a multi-omics data management and integration software platform to pharmaceutical, agriscience, and consumer goods organizations.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Data Integration, Vertical SaaS, Data Governance

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Infrastructure

Keywords

multi-omics data managementbioinformatics platformFAIR datadata cataloglife science data platformAI-ready datadata curationdata integrationdata governancedrug discoverydata fabricVertical SaaSagriscienceagentic analyticsLLM integration

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genestack Comparables

Compare Genestack with similar companies based on industry and business-model similarity.

Genestack comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Siemens
79%
LatchBio
79%
Collate
77%

Genestack Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 1, 2016
SeedJul 10, 2012

Key People

Founding team and executive leadership

Misha Kapushesky

Chief Executive Officer and Founder

Founding Team

Katia Kapushesky

Chief Operating Officer

Executive Team

Genestack Investors

Notable investors and investment history

Genestack investors
InvestorRounds
Innovate UKGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 67% MoM, reaching 2.3K.

  • Dec 4, 2025

    Monthly visitors grew 1028% MoM, from 112 to 1.3K.

Genestack Filings

Explore SEC and related filing metadata, where available.

Genestack filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Genestack's valuation, stock price, and market status.

Is Genestack a public or private company?

Genestack is a private company.

What is the current stock price of Genestack?

Genestack is a private company with no public stock price. No recent secondary market data is available.

How much is Genestack worth (valuation)?

Valuation information for Genestack is not publicly available.

Can I buy Genestack stock?

Genestack shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Genestack's last funding round?

Genestack's most recent funding round was Grant on February 1, 2016.

Who are the main investors in Genestack?

Key investors in Genestack include Innovate UK.

Will Genestack IPO soon?

No public IPO plans have been announced for Genestack.

How can I track Genestack secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genestack's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge
Employee Range45
Year Founded2012
Last FundingFeb 1, 2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?